Back
Corporate News
Rekvina Laboratories acquires Radiant Parenterals via share swap valued at Rs 4,62,77,500
12-Aug-2026, 06:52
Rekvina Laboratories Limited is acquiring 100% of Radiant Parenterals Limited through a share swap, issuing 46,27,750 new equity shares at Rs 10 per share, valued at a total consideration of Rs 4,62,77,500. Simultaneously, Rekvina is conducting a preferential allotment of 4,60,000 new equity shares to Amitkumar Arunkumar Rao and Amitkumar Arunkumar Rao HUF for Rs 46,00,000 in cash, priced at Rs 10 per share including a Rs 5 premium. The acquisition, deemed an arm's length transaction, is expected to complete within 15 days of regulatory approvals, including in-principle exchange approval and a special resolution. The moves are intended to expand Rekvina’s market presence and create shareholder value, although they will result in dilution of existing shareholders’ ownership.
Rekvina Laboratories Limited is acquiring 100% of Radiant Parenterals Limited through a share swap, issuing 46,27,750 new equity shares at Rs 10 per share, valued at a total consideration of Rs 4,62,77,500. Simultaneously, Rekvina is conducting a preferential allotment of 4,60,000 new equity shares to Amitkumar Arunkumar Rao and Amitkumar Arunkumar Rao HUF for Rs 46,00,000 in cash, priced at Rs 10 per share including a Rs 5 premium. The acquisition, deemed an arm's length transaction, is expected to complete within 15 days of regulatory approvals, including in-principle exchange approval and a special resolution. The moves are intended to expand Rekvina’s market presence and create shareholder value, although they will result in dilution of existing shareholders’ ownership.